Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

SP ? 4.8mm WN, SLA? 8mm, Ti, Loxim: medical device reports filed with FDA

3,703 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

3,703
device reports naming the brand
0% of all MAUDE reports · about 542 a year
726
reports, 12 months to August 2026
674 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

3,703 medical device reports received by FDA name the brand "SP ? 4.8mm WN, SLA? 8mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

726 reports arrived in the 12 months to August 2026, close to the 674 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (62.2%), loss of osseointegration (35.6%) and difficult to insert (0.2%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

085170Sep 2021: 17Oct 2021: 25Nov 2021: 35Dec 2021: 242022Jan 2022: 54Feb 2022: 41Mar 2022: 40Apr 2022: 40May 2022: 39Jun 2022: 28Jul 2022: 50Aug 2022: 40Sep 2022: 17Oct 2022: 43Nov 2022: 42Dec 2022: 492023Jan 2023: 25Feb 2023: 23Mar 2023: 42Apr 2023: 39May 2023: 47Jun 2023: 49Jul 2023: 67Aug 2023: 71Sep 2023: 63Oct 2023: 62Nov 2023: 46Dec 2023: 602024Jan 2024: 65Feb 2024: 44Mar 2024: 57Apr 2024: 71May 2024: 75Jun 2024: 57Jul 2024: 63Aug 2024: 47Sep 2024: 55Oct 2024: 42Nov 2024: 64Dec 2024: 642025Jan 2025: 43Feb 2025: 27Mar 2025: 57Apr 2025: 31May 2025: 0Jun 2025: 170Jul 2025: 62Aug 2025: 59Sep 2025: 45Oct 2025: 66Nov 2025: 77Dec 2025: 812026Jan 2026: 59Feb 2026: 66Mar 2026: 42Apr 2026: 51May 2026: 59Jun 2026: 66Jul 2026: 54Aug 2026: 60

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03597182019: 16120192020: 26320202021: 32320212022: 48320222023: 59420232024: 70420242025: 71820252026: 4572026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,703
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report96.2%3,563
Voluntary report0%0
User facility report0%0
Distributor report3.8%140
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,30362.2%62.8%
Loss of osseointegration1,32035.6%22.4%
Difficult to insertthe device was hard to insert80.2%0.4%
Fracturea broken bone60.2%1.6%
Unintended movement40.1%0%
Separation failure10%0.1%
Unstable10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,03127.8%
Painpain, site not specified60516.3%
Tissue damage2897.8%
Inflammationinflammation1534.1%
Hemorrhage/blood loss/bleeding1183.2%
Swelling/ edema1113%
Hyperresponsive to stimuli441.2%
Abscessa collection of pus411.1%
Fistula300.8%
Numbnessnumbness200.5%
Failure of implant170.5%
Hypersensitivity/allergic reaction150.4%
Sinus perforation140.4%
Swellingswelling130.4%
Increased sensitivity90.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureSP ? 4.8mm WN, SLA? 8mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports3,7033,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer96.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about SP ? 4.8mm WN, SLA? 8mm, Ti, Loxim reports

How many FDA reports name SP ? 4.8mm WN, SLA? 8mm, Ti, Loxim?

3,703 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 726 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (62.2%), loss of osseointegration (35.6%), difficult to insert (0.2%), fracture (0.2%) and unintended movement (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (96.2%) and distributor reports (3.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that SP ? 4.8mm WN, SLA? 8mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.